bispecific antibodies

FDA grants priority reviews for Pfizer's Prevnar 20 for kids and Roche lymphoma candidate
Endpoints
Sun, 01/8/23 - 09:59 pm
FDA
priority review
Pfizer
Prevnar 20
vaccines
Roche
bispecific antibodies
glofitamab
lymphoma
AbbVie's Roche-rivaling blood cancer bispecific gets FDA priority review, triggering Genmab payday
Fierce Biotech
Mon, 11/21/22 - 10:12 am
AbbVie
Genmab
FDA
Roche
epcoritamab
bispecific antibodies
relapsed or refractory large B-cell lymphoma
Roche's Vabysmo lands clinical counterpunch in ophthalmology brawl with Eylea
Fierce Pharma
Thu, 10/27/22 - 11:02 am
Roche
Genentech
Vabysmo
bispecific antibodies
Eylea
Buy now, pay later: Jazz hands over $50M for Zymeworks' phase 3 HER2-directed bispecific
Fierce Biotech
Wed, 10/19/22 - 10:42 am
Jazz Pharmaceuticals
Zymeworks
HER2 inhbitor
bispecific antibodies
Seagen, amid deal rumors, spends $50M on a dual-targeting cancer drug
BioPharma Dive
Mon, 09/26/22 - 11:20 pm
Seagen
Merck
Lava Therapeutics
bispecific antibodies
LAVA-1223
J&J bags first nod for multiple myeloma bispecific to complement its own CAR-T offering
Fierce Pharma
Thu, 08/25/22 - 07:43 pm
JNJ
Europe
bispecific antibodies
Multiple Myeloma
Tecvayli
teclistamab
Amgen takes BiTEs out of pipeline, dropping BCMA, PSMA assets in light of data and competition
Fierce Biotech
Fri, 08/5/22 - 10:42 am
Amgen
BCMA
PSMA
Multiple Myeloma
bispecific antibodies
Following bispecific deal with Pfizer, quiet California biotech raises $65M, heads to the clinic
Endpoints
Tue, 06/14/22 - 07:25 pm
Dren Bio
Pfizer
bispecific antibodies
ASCO22: J&J, Pfizer trade BCMA bispecific data in myeloma
Pharmaforum
Mon, 06/6/22 - 09:52 am
JNJ
Pfizer
ASCO 2022
bispecific antibodies
relapsed or refractory multiple myeloma
Roche trumpets new glofitamab data in lymphoma at ASCO
Pharmaforum
Fri, 05/27/22 - 10:24 am
Roche
ASCO 2022
glofitamab
lymphoma
bispecific antibodies
Cancer biotech Rondo gets $67M to step on the gas with next-gen bispecific drugs
MedCity News
Fri, 03/4/22 - 09:38 am
Rondo Therapeutics
bispecific antibodies
solid tumors
cancer
funding
Roche looks to compete against a blockbuster with its newly approved vision drug
Stat
Sun, 01/30/22 - 11:53 am
Roche
FDA
bispecific antibodies
Regeneron
Vabysmo
wet age-related macular degeneration
diabetic macular edema
Dren Bio Announces Research Collaboration and License Agreement with Pfizer to Discover and Advance Multiple Therapeutic Antibodies
BioSpace
Tue, 01/11/22 - 11:32 am
Pfizer
Dren Bio
R&D
bispecific antibodies
J&J goes after another FDA approval for a cancer bispecific
Pharmaforum
Thu, 12/30/21 - 10:53 am
JNJ
bispecific antibodies
cancer
FDA
Janssen
teclistamab
Multiple Myeloma
ASH: Roche uncorks eyepopping responses in bispecific test, hoping to add a jewel to its future portfolio
Endpoints
Sun, 12/12/21 - 11:31 pm
ASH2021
Roche
Genentech
bispecific antibodies
blood cancer
mosunetuzumab
J&J spends $100M upfront, with $1.2B in biobucks, to join Roche and Regeneron in bispecific blood cancer race
Fierce Biotech
Mon, 10/4/21 - 11:08 am
JNJ
Xencor
biobucks
Roche
Regeneron
bispecific antibodies
blood cancers
plamotamab
FDA starts review of Roche’s eye disease drug, setting up 2022 verdict
Pharmaforum
Thu, 07/29/21 - 10:57 pm
Roche
faricimab
bispecific antibodies
diabetic macular edema
wet age-related macular degeneration
Hemab raises $55M to target multiple rare bleeding indications
Fierce Biotech
Thu, 07/22/21 - 10:55 am
Hemab
funding
monoclonal antibodies
bispecific antibodies
Roche takes the Tim-3 battle to Novartis
EP Vantage
Thu, 07/22/21 - 10:53 am
Roche
sabatolimab
Novartis
RG7769
bispecific antibodies
J&J, Vor ally to assess bispecific and stem cell therapy in AML
Fierce Biotech
Fri, 07/9/21 - 10:13 am
JNJ
Vor Biopharma
bispecific antibodies
stem cell therapy
AML

Pages